Meno-Joy II
Natural health product licensed in Canada
- Other names
- Dr Nutrition 360 Meno-Joy II, Maplelife Nutrition Meno-Joy II, Nutralab Canada Meno-Joy II
- Licence holder
- Nutralab Canada Corp.
- NPN or DIN-HM
- 80059368
- Status
- Active licence
- Licence date
- 30 March 2015
- Revision date
- 5 June 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glycine max Source : Glycine max - Graine Potency : 40 % Soy isoflavone extract | 25 milligramme | Not calculated |
| Actaea racemosa Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 milligramme | 50 milligramme | Not calculated |
| Vitamine E Source : Acétate de dl-alpha tocophéryle Potency : 35 UI | 23.45 mg AT | Not calculated |
| Valeriana officinalis Source : Valeriana officinalis Potency : 0.8 % Valerenic acid | 30 milligramme | Not calculated |
| Valeriana officinalis Source : Racine et rhizome Potency : 0.8 % Valerenic acid | 30 milligramme | Not calculated |
| Angelica sinensis Source : Angelica sinensis - Racine | 100 milligramme | Not calculated |
| Salvia miltiorrhiza Source : Salvia miltiorrhiza - racine et rhizome | 50 milligramme | Not calculated |
| Paeonia lactiflora Source : Paeonia lactiflora | 50 milligramme | Not calculated |
| Paeonia lactiflora Source : Racine | 50 milligramme | Not calculated |
| Ligustrum lucidum Source : Ligustrum lucidum - Fruit | 50 milligramme | Not calculated |
| Scutellaria baicalensis Source : Scutellaria baicalensis - racine | 50 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Microcrystalline cellulose, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Used in Herbal Medicine to) help(s) relieve symptoms associated with menopause. Used in Herbal Medicine to help relieve premenstrual symptoms. An antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80059368
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging